Suvanza Pharma, LLC

OTC: SUVZ · Healthcare · Biotechnology

PublicHQ Miami Beach, FL · Miami-DadeReports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 62

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ market scale, listing tenure

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-08-02

Market cap

$1.0M

as of 2026-08-02

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Suvanza Pharma, LLC’s financial profile?

Suvanza Pharma, LLC has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Dermata Therapeutics, Inc.——Tocca Life Holdings Inc——PharmaCom BioVet, Inc.——Lakewood-Amedex Biotherapeutics Inc. Common Stock——RushNet, Inc.——ZyVersa Therapeutics, Inc.——

Neighbors

Miami-Dade →

Palantir Technologies Inc.$4.5B78B+Royal Caribbean Cruises Ltd.$17.9B80B+Carnival Corporation & plc$26.6B72B MasTec, Inc.$14.3B77B+Lennar Corporation$34.2B74B Watsco, Inc.$7.2B73B

Key facts

CEONardo Zaias

SectorHealthcare

IndustryBiotechnology

HeadquartersMiami Beach, FL

ExchangeOTC: SUVZ

Employees—

IPO date1995-02-24

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.